11 results on '"Lopes FL"'
Search Results
2. Propolis consumption by asymptomatic HIV-individuals: Better redox state? A prospective, randomized, double-blind, placebo-controlled trial.
- Author
-
Tasca KI, Conte FL, Correa CR, Santiago KB, Cardoso EO, Manfio VM, Garcia JL, Berretta AA, Sartori AA, Honorio MDS, Souza LDR, and Sforcin JM
- Subjects
- Humans, Antioxidants pharmacology, Longitudinal Studies, Prospective Studies, Oxidation-Reduction, Oxidative Stress, Double-Blind Method, Propolis pharmacology, HIV Infections drug therapy
- Abstract
Propolis is a natural product has many biological properties of clinical interest, such as anti-inflammatory and antioxidant. Considering that people living with HIV/aids (PLWHA) on effective combined antiretroviral therapy (cART) present early aging due to an intense immune activation, inflammation, and redox imbalance, propolis consumption could offer a benefit to such patients. This double-blind longitudinal study evaluated whether Brazilian green propolis pills intake (500 mg/day for three months) would decrease the oxidative stress of virological suppressed HIV-individuals. To compare each group (propolis, n = 20 versus placebo, n = 20) in both moments (M0, before and M1, after the intervention), the following markers were assessed: plasma malondialdehyde (MDA), carbonylation, total oxide nitric, total antioxidant capacity (TAP), superoxide dismutase, catalase, and NFkB and NRF2 gene expression. Data were analyzed using Poisson, Gamma distribution and ANOVA followed by Tukey-Kramer. The groups were homogeneous regarding age, gender, time of diagnosis/ treatment, cART scheme, CD4
+ T cell count, and no changes were observed in the diet food, or patients' lifestyles. A decreased MDA concentration was seen in the propolis group (M0 = 0.24 ± 0.13, M1 = 0.20 ± 0.10 protein nmol/mg; p = 0.005) as well as a slight but non-significant increase of TAP (M0 = 49.07 ± 13.26, M1 = 52.27 ± 14.86%; p = 0.06). One may conclude that propolis promoted a lower lipid peroxidation and improved the antioxidant system, suggesting that its use may be beneficial to PLWHA in an attempt to contain the intense inflammatory and oxidant activity., Competing Interests: Conflict of interest statement The authors declare that they have no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
3. Brazilian red propolis exerts a cytotoxic action against prostate cancer cells and upregulates human monocyte functions.
- Author
-
Santiago KB, Rodrigues JCZ, de Oliveira Cardoso E, Conte FL, Tasca KI, Romagnoli GG, Aldana-Mejía JA, Bastos JK, and Sforcin JM
- Subjects
- Male, Humans, Interleukin-10 metabolism, Interleukin-10 pharmacology, Monocytes, Tumor Necrosis Factor-alpha metabolism, Brazil, Interleukin-6 metabolism, Prostate, HLA-DR Antigens metabolism, HLA-DR Antigens pharmacology, Propolis chemistry, Antineoplastic Agents pharmacology, Prostatic Neoplasms drug therapy, Prostatic Neoplasms metabolism
- Abstract
Different propolis samples can be obtained in Brazil, such as green, brown and red. Studies related to Brazilian red propolis (BRP) have increased in the last few years, so the aim of this study was to investigate its effects on the prostate cell lines LNCaP and PC-3 and on human monocytes. BRP chemical composition was analyzed by HPLC-DAD, the viability of monocyte and cancer cell by MTT assay. Cytokine production (TNF-α, IL-1β, IL-6, IL-10) by monocytes was quantitated by ELISA, the expression of cell markers (TLR-2, TLR-4, HLA-DR, CD80) and reactive oxygen species by flow cytometry. The candidacidal activity and the effects of supernatant of treated monocytes on tumor cells were assessed. BRP affected LNCaP viability after 48 and 72 h, while PC-3 cells were more resistant over time. BRP upregulated CD80 and HLA-DR expression, and stimulated TNF-α, IL-6 and IL-10 production. BRP enhanced the fungicidal activity of monocytes, displayed an antioxidant action and the supernatant of BRP-treated monocytes diminished LNCaP viability. In the search for new immunomodulatory and antitumoral agents, BRP exerted a selective cytotoxic activity on prostate cancer cells and an immunomodulatory action, suggesting its potential for clinical trials with oncological patients and for the discovery of new immunomodulatory and antitumor drugs., (© 2022 John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
4. Brazilian green propolis: A novel tool to improve the cytotoxic and immunomodulatory action of docetaxel on MCF-7 breast cancer cells and on women monocyte.
- Author
-
de Oliveira Cardoso E, Santiago KB, Conti BJ, Conte FL, Tasca KI, Romagnoli GG, de Assis Golim M, Rainho CA, Bastos JK, and Sforcin JM
- Subjects
- Docetaxel pharmacology, Female, Humans, MCF-7 Cells, Monocytes, Breast Neoplasms drug therapy, Propolis pharmacology
- Abstract
Docetaxel (DTX) is used against breast cancer despite its side effects such as toxicity and immunosuppression. Here we investigated the cytotoxic and immunomodulatory effects of the ethanol solution extract of propolis (EEP) in combination with DTX on MCF-7 breast cancer cells and on women's monocyte. The cytotoxic potential of EEP + DTX was assessed by MTT assay and the type of tumor cell death was evaluated by flow cytometry. The effects of EEP + DTX on the migration and invasion of MCF-7 cells were analyzed. Cytokine production by monocytes was assessed by ELISA and the expression of cell surface markers was evaluated by flow cytometry. We also assessed the fungicidal activity of monocytes against Candida albicans and the generation of reactive oxygen species (ROS). Finally, the impact of the supernatants of treated monocytes in the viability, migration, and invasiveness of tumor cells was assessed. EEP enhanced the cytotoxicity of DTX alone against MCF-7 cells by inducing necrosis and inhibiting their migratory ability. EEP + DTX exerted no cytotoxic effects on monocytes and stimulated HLA-DR expression, TNF-α, and IL-6 production, exerted an immunorestorative action in the fungicidal activity, and reduced the oxidative stress. Our findings have practical implications and reveal new insights for complementary medicine., (© 2021 John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
5. Propolis increases Foxp3 expression and lymphocyte proliferation in HIV-infected people: A randomized, double blind, parallel-group and placebo-controlled study.
- Author
-
Conte FL, Tasca KI, Santiago KB, de Oliveira Cardoso E, Romagnoli GG, de Assis Golim M, Braz AMM, Berretta AA, do Rosário de Souza L, and Sforcin JM
- Subjects
- Adult, Anti-HIV Agents adverse effects, Anti-Inflammatory Agents administration & dosage, Anti-Inflammatory Agents pharmacology, Cytokines blood, Double-Blind Method, Female, Forkhead Transcription Factors genetics, Humans, Immunomodulating Agents administration & dosage, Immunomodulating Agents pharmacology, Inflammation drug therapy, Inflammation pathology, Leukocytes, Mononuclear drug effects, Leukocytes, Mononuclear metabolism, Lymphocytes drug effects, Lymphocytes metabolism, Male, Middle Aged, Propolis pharmacology, Anti-HIV Agents administration & dosage, Cell Proliferation drug effects, HIV Infections drug therapy, Propolis administration & dosage
- Abstract
HIV infection and the prolonged use of antiretroviral therapy (ART) contribute to persistent inflammation and immune deregulation in people living with HIV/AIDS (PLWHA). Propolis is a bee product with plenty of biological properties, including immunomodulatory and anti-inflammatory action. This work aimed to evaluate possible changes in the immune/inflammatory response in PLWHA under ART after propolis intake. Asymptomatic PLWHA were double-blindly randomized into parallel groups receiving propolis (500 mg/day, n = 20) for 3 months or placebo (n = 20). Plasma cytokines (TNF-α, IL-2, IL-4, IL-6, IL-10 and IL17) were evaluated by cytometric bead array; cytokine production by PBMC (IFN-γ, IL-5, IL-17, IL-10, IL-1β, IL-18, and IL-33) was assessed by ELISA; gene expression (T-bet, GATA-3, RORγt and Foxp3) was determined by RT-qPCR, and cell proliferation was analysed by flow cytometry using CFSE staining. The average of gender, age, CD4
+ /CD8+ T cell count, time of diagnosis and treatment were similar in both groups. No differences were observed in cytokine levels nor in inflammasome activation. However, Pearson's correlation showed that IL-10 was directly correlated to CD4+ T cell count and inversely to IFN-γ after treatment with propolis. Foxp3 expression and lymphocyte proliferation increased in the propolis group. Data suggested that daily propolis consumption may improve the immune response and decrease the inflammatory status in asymptomatic PLWHA under ART., (Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
6. Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment.
- Author
-
Ripari N, Sartori AA, da Silva Honorio M, Conte FL, Tasca KI, Santiago KB, and Sforcin JM
- Subjects
- Animals, Humans, Immunologic Factors immunology, SARS-CoV-2 drug effects, SARS-CoV-2 immunology, Antiviral Agents immunology, Antiviral Agents therapeutic use, COVID-19 immunology, Immunologic Factors therapeutic use, Propolis immunology, Propolis therapeutic use, COVID-19 Drug Treatment
- Abstract
Objectives: Viral outbreaks are a frequent concern for humans. A great variety of drugs has been used to treat viral diseases, which are not always safe and effective and may induce adverse effects, indicating the need for new antiviral drugs extracted from natural sources. Propolis is a bee-made product exhibiting many biological properties. An overview of viruses, antiviral immunity, propolis safety and its immunomodulatory and antiviral action is reported, as well as perspectives for coronavirus disease 2019 (COVID-19) treatment. PubMed platform was used for data collection, searching for the keywords "propolis", "virus", "antiviral", "antimicrobial" and "coronavirus"., Key Findings: Propolis is safe and exerts antiviral and immunomodulatory activity; however, clinical trials should investigate its effects on individuals with viral diseases, in combination or not with antiviral drugs or vaccines., Summary: Regarding COVID-19, the effects of propolis should be investigated directly on the virus in vitro or on infected individuals alone or in combination with antiviral drugs, due to its immunomodulatory and anti-inflammatory action. Propolis administration simultaneously with vaccines should be analyzed, due to its adjuvant properties, to enhance the individuals' immune response. The search for therapeutic targets may be useful to find out how propolis can help to control COVID-19., (© The Author(s) 2021. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
7. Propolis from southeastern Brazil produced by Apis mellifera affects innate immunity by modulating cell marker expression, cytokine production and intracellular pathways in human monocytes.
- Author
-
Conte FL, Santiago KB, Conti BJ, Cardoso EO, Oliveira LPG, Feltran GDS, Zambuzzi WF, Golim MA, Cruz MT, and Sforcin JM
- Subjects
- Adult, Animals, Bacterial Toxins immunology, Bees, Biomarkers metabolism, Brazil, Cell Survival drug effects, Enterotoxins immunology, Escherichia coli Proteins immunology, Humans, Monocytes immunology, NF-kappa B metabolism, Tretinoin pharmacology, Cytokines metabolism, Immunity, Innate drug effects, Monocytes drug effects, Propolis pharmacology
- Abstract
Objectives: Propolis is a bee-made product used for centuries due to its diverse biological properties, including its immunomodulatory action. This work aimed at investigating whether propolis may affect monocyte functions challenged with retinoic acid (RA), B subunit of Escherichia coli heat-labile enterotoxin (EtxB), human melanoma-associated antigen-1 (MAGE-1) and lipopolysaccharide (LPS)., Methods: Monocytes from healthy donors were treated with the stimuli separately or in the presence of propolis. Cell viability was evaluated by MTT assay, cell marker expression was assessed by flow cytometry, cytokine production by ELISA, gene expression by RT-qPCR., Key Findings: Propolis alone maintained TLR-2, TLR-4, HLA-DR, CD40 and CD80 expression in the monocytes; however, its combination with either MAGE-1 or LPS decreased CD40 expression triggered by the stimuli. Propolis maintained RA action on cell marker expression. Propolis inhibited TNF-α (with either EtxB or MAGE-1) and IL-6 (with either RA or MAGE-1), and increased IL-10 (with MAGE-1) production. Propolis downmodulated LC3 expression induced by LPS. It also induced a lower NF-kB expression than control cells and its combination with RA induced a higher expression than the stimulus alone., Conclusions: Propolis potentially affected innate immunity by downmodulating the monocytes pro-inflammatory activity., (© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Pharmaceutical Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
8. The chemical composition and events related to the cytotoxic effects of propolis on osteosarcoma cells: A comparative assessment of Colombian samples.
- Author
-
Mora DPP, Santiago KB, Conti BJ, de Oliveira Cardoso E, Conte FL, Oliveira LPG, de Assis Golim M, Uribe JFC, Gutiérrez RM, Buitrago MR, Popova M, Trusheva B, Bankova V, García OT, and Sforcin JM
- Subjects
- Animals, Antioxidants chemistry, Antioxidants pharmacology, Bone Neoplasms metabolism, Cell Survival drug effects, Colombia, Cytotoxins chemistry, Cytotoxins pharmacology, Diterpenes chemistry, Diterpenes pharmacology, Dog Diseases metabolism, Dog Diseases pathology, Dogs, Flavonoids chemistry, Flavonoids pharmacology, Gas Chromatography-Mass Spectrometry, Osteosarcoma metabolism, Reactive Oxygen Species metabolism, Signal Transduction drug effects, Triterpenes chemistry, Triterpenes pharmacology, Tumor Cells, Cultured, Apoptosis drug effects, Bone Neoplasms pathology, Osteosarcoma pathology, Propolis chemistry, Propolis pharmacology
- Abstract
Osteosarcoma (OSA) is a type of bone cancer showing an aggressive biological behavior with metastatic progression. Because propolis potential for the development of new antitumoral drugs has been indicated, we evaluated the chemical composition of Colombian propolis samples and the mechanisms involved in their cytotoxic effects on OSA cells. The chemical composition was analyzed by GC-MS and the DPPH free radical scavenging activity was measured. Cluster and principal components analysis were used to establish an association with their inhibitory concentration 50% (IC
50 ). Cell viability was analyzed by MTT assay; apoptosis was determined by flow cytometry; mitochondrial membrane permeability and reactive oxygen species were evaluated by rhodamine 123 and DCFH-DA. Transwell assay was used to evaluate the invasiveness of propolis-treated cells. Samples were grouped: Cluster 1 contained diterpenes and benzophenones and showed the highest antiradical activity; Cluster 2 was characterized by triterpenes, fatty acid, and diterpenes. Usm contained diterpenes and triterpenes different of the other samples and Sil contained triterpenes and flavonoids. Apoptosis, mitochondrial membrane alteration, and suppression of cell invasion were the main mechanisms involved in the inhibition of OSA cells in vitro, suggesting the potential of Colombian propolis to discover new antitumor drugs., (© 2018 John Wiley & Sons, Ltd.)- Published
- 2019
- Full Text
- View/download PDF
9. A new chemotherapeutic approach using doxorubicin simultaneously with geopropolis favoring monocyte functions.
- Author
-
Oliveira LPG, Conte FL, de Oliveira Cardoso E, Conti BJ, Santiago KB, de Assis Golim M, da Silva Feltran G, Zambuzzi WF, and Sforcin JM
- Subjects
- Adult, Animals, Bees, Cell Survival drug effects, Cells, Cultured, Cytokines analysis, Cytokines immunology, Humans, Monocytes cytology, Monocytes immunology, Biological Products pharmacology, Doxorubicin pharmacology, Immunologic Factors pharmacology, Monocytes drug effects, Propolis pharmacology
- Abstract
Aims: Chemotherapy has been widely used to treat cancer although it may affect non-target cells involved in the immune response. This work aimed at elucidating whether the chemotherapeutic agent doxorubicin in combination with geopropolis produced by Melipona fasciculata Smith could affect nontumor immune cells, evaluating their immunomodulatory effects on human monocytes., Main Methods: Cell viability, expression of cell markers (HLA-DR, TLR-2, TLR-4, C80 and CD40), cytokine production (TNF-α, IL-1β, IL-6 and IL-10), intracellular pathways (NF-κB and autophagy), the microbicidal activity of monocytes and hydrogen peroxide (H
2 O2 ) production were analyzed., Key Findings: Data showed that doxorubicin + geopropolis diminished IL-6 secretion, stimulated TNF-α and IL-10 production, TLR-4 and CD80 expression, NF-κB and autophagy pathway, as well as the bactericidal activity., Significance: Our findings revealed a new chemotherapeutic approach using doxorubicin simultaneously with geopropolis without affecting human monocytes viability and exerting immunomodulatory effects, favoring cell functions. While doxorubicin altered some immunological parameters, the addition of geopropolis compensated some changes., (Copyright © 2018 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
10. Phenolic compounds alone or in combination may be involved in propolis effects on human monocytes.
- Author
-
Cardoso EO, Conti BJ, Santiago KB, Conte FL, Oliveira LP, Hernandes RT, Golim MA, and Sforcin JM
- Subjects
- Anti-Bacterial Agents pharmacology, Antifungal Agents pharmacology, Apitherapy, Drug Synergism, Humans, Hydrogen Peroxide metabolism, Immunologic Factors pharmacology, Interleukin-10 metabolism, Interleukin-6 metabolism, Monocytes metabolism, Propolis chemistry, Toll-Like Receptor 2 metabolism, Toll-Like Receptor 4 metabolism, Tumor Necrosis Factor-alpha metabolism, Caffeic Acids pharmacology, Coumarins pharmacology, Monocytes drug effects, Phenols pharmacology, Phenylpropionates pharmacology, Propolis pharmacology
- Abstract
Objectives: Propolis is a natural product with a complex chemical composition. Its isolated compounds exert biological activities; however, its synergistic effects are unknown. The involvement of phenolic acids (caffeic - Caf, dihydrocinnamic - Cin and p-coumaric - Cou) alone or in combination was investigated in the action of propolis in human monocytes., Methods: Cell viability was analysed by MTT assay; TNF-α, IL-6 and IL-10 production by enzyme-linked immunosorbent assay (ELISA); cell markers expression by flow cytometry; colony-forming units were counted to assess the microbicidal activity; and H
2 O2 production was analysed by colorimetric assay., Key Findings: Treatments did not affect monocytes viability. Propolis and combinations containing Caf enhanced TNF-α production by resting cells. Propolis, Cin, Cou and Caf + Cin stimulated IL-6 production. All treatments upregulated IL-10. In LPS-stimulated cells, treatments downregulated IL-6 and maintained TNF-α and IL-10 production. A lower TLR-2 expression was seen than propolis. Caf + Cin enhanced TLR-4 expression. Propolis, Caf and Caf + Cin stimulated H2 O2 production, whereas propolis, Cin, Cou, and Caf + Cin + Cou induced a higher fungicidal activity. Cin and Cin + Cou increased the bactericidal activity of human monocytes., Conclusion: Propolis activated human monocytes, and acids were involved differently in propolis activity., (© 2016 Royal Pharmaceutical Society.)- Published
- 2017
- Full Text
- View/download PDF
11. Immunomodulatory/inflammatory effects of geopropolis produced by Melipona fasciculata Smith in combination with doxorubicin on THP-1 cells.
- Author
-
Oliveira LP, Conte FL, Cardoso EO, Conti BJ, Santiago KB, Golim MA, Cruz MT, and Sforcin JM
- Subjects
- Animals, Antineoplastic Combined Chemotherapy Protocols toxicity, B7-1 Antigen, Biomarkers metabolism, Cell Line, Tumor, Cell Survival drug effects, Dose-Response Relationship, Drug, Doxorubicin toxicity, HLA-DR Antigens metabolism, Humans, Inflammation chemically induced, Inflammation immunology, Inflammation metabolism, Inflammation Mediators immunology, Interleukin-6 metabolism, Macrophages immunology, Macrophages metabolism, Monocytes immunology, Monocytes metabolism, Propolis toxicity, Time Factors, Toll-Like Receptor 2 metabolism, Toll-Like Receptor 4 metabolism, Tumor Necrosis Factor-alpha metabolism, Antineoplastic Combined Chemotherapy Protocols pharmacology, Bees, Doxorubicin pharmacology, Inflammation prevention & control, Inflammation Mediators metabolism, Macrophages drug effects, Monocytes drug effects, Propolis pharmacology
- Abstract
Objectives: Geopropolis (GEO) in combination with doxorubicin (DOX) reduced HEp-2 cells viability compared to GEO and DOX alone. A possible effect of this combination on the innate immunity could take place, and its effects were analysed on THP-1 cell - a human leukaemia monocytic cell line used as a model to study monocyte activity and macrophage activity, assessing cell viability, expression of cell markers and cytokine production., Methods: THP-1 cells were incubated with GEO, DOX and their combination. Cell viability was assessed by MTT assay, cell markers expression by flow cytometry and cytokine production by ELISA., Key Findings: GEO + DOX did not affect cell viability. GEO alone or in combination increased TLR-4 and CD80 but not HLA-DR and TLR-2 expression. GEO stimulated TNF-α production while DOX alone or in combination did not affect it. GEO alone or in combination inhibited IL-6 production., Conclusions: GEO exerted a pro-inflammatory profile by increasing TLR-4 and CD80 expression and TNF-α production, favouring the activation of the immune/inflammatory response. GEO + DOX did not affect cell viability and presented an immunomodulatory action. Lower concentrations of DOX combined to GEO could be used in cancer patients, avoiding side effects and benefiting from the biological properties of GEO., (© 2016 Royal Pharmaceutical Society.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.